Additional file 3: Table S3. Characteristics of the studies, environment and training set-ups for monitoring stress parameters, measures of stress parameters and performance, results of intervention, and validation according to the Kirkpatrick level of evidence and Messick’s validity framework. The detailed evidence synthesis of the reviewed articles.

Additional file 2. Characteristics of included and excluded patients.

Additional file 4. Stacked histograms of time intervals between start of etanercept/adalimumab therapy and baseline/follow-up measurements.

Abstract Background Etanercept (ETN) and adalimumab (ADA) are considered equally effective biologicals in the treatment of arthritis in juvenile idiopathic arthritis (JIA) but no studies have compared their impact on patient-reported well-being. The objective of this study was to determine whether ETN and ADA have a differential effect on patient-reported well-being in non-systemic JIA using real-world data. Methods Biological-naive patients without a history of uveitis were selected from the international Pharmachild registry. Patients starting ETN...

Crisis Resolution Teams (CRT) for rapid assessment and short-term treatment of mental health problems have increasingly been implemented internationally over the last decades. Among the Nordic countries, the CRT model has been particularly influential in Norway, where ‘Ambulante akutteam (AAT)’ is a widespread psychiatric emergency service for adult patients. However, the clinical practice of these teams varies significantly. To aid further development of the service and guide future research efforts, we carried out a scoping...

Supplementary Material 1

Abstract Background Very low birth weight (VLBW: ≤1500 g) is associated with multiple short and long-term complications. This study aimed to examine outcomes and predictors of functioning, mental health, and health-related quality of life in adults born with VLBW. Methods In this prospective longitudinal cohort study, 67 VLBW and 102 control participants were assessed using the Adult Self-Report of the Achenbach System of Empirically Based Assessment and Global Assessment of Functioning at 26 years, and...

Supplemental data for JCEM.

Supplemental data for JCEM.

Rationale:The evidence base for acute post-stroke rehabilitation is inadequate and global guideline recommendations vary.Aim:To define optimal early mobility intervention regimens for ischemic stroke patients of mild and moderate severity.Hypotheses:Compared with a prespecified reference arm, the optimal dose regimen(s) will result in more participants experiencing little or no disability (mRS 0–2) at 3 months post-stroke (primary), fewer deaths at 3 months, fewer and less severe complications during the intervention period, faster recovery of unassisted walking, and...

Supplemental material, sj-docx-1-tec-10.1177_17474930221126592 for Does implementation of a standardized pathway of stroke care affect functional outcome after stroke? by Elin Bergh, Torunn Askim, Ole Morten Rønning, Jurate Šaltyteė Benth, Hild Fjærtoft and Bente Thommessen in International Journal of Stroke

Background:A stroke care pathway (SCP) was introduced in Norway in 2018. The goal of the pathway was to avoid delay in treatment and diagnostics of acute stroke and to secure treatment according to national guidelines. In this study, we aimed to evaluate how the implementation of the SCP affects outcome after stroke.Methods:We performed a register-based study using data from the Norwegian Stroke Register that covers 87% of acute stroke patients in Norway. Patients included 1...

Supplemental data for JCEM.

Abstract Background Traditional observational studies have shown an inverse association between body mass index (BMI) and lung cancer risk. Mendelian randomization (MR) analysis using genetic variants as instruments for BMI may clarify the nature of the association. Aims We studied the causal association between BMI and lung cancer incidence using observational and MR approaches. Methods We followed up 62,453 cancer-free Norwegian adults from 1995–97 (HUNT2) until 2017. BMI at baseline in HUNT2 was classified as...

Additional file 1: Supplementary Table 1. Complete Case Analysis related to Table 2. Hazard Ratios (HR) and 95% confidence intervals (CI) for AMI during follow-up. Supplementary Table 2. Mechanisms related to missing on the physical activity question. Supplementary Table 3. Number (n, %) of participants* without and with Acute Myocardial Infarction (AMI) in Complete Case.

Supplementary Material 1

Supplementary Material 1

Additional file 1. Overlapping histograms of propensity score for receiving adalimumab (ADA), n = 158.

Additional file 1. Overlapping histograms of propensity score for receiving adalimumab (ADA), n = 158.

Additional file 2. Characteristics of included and excluded patients.

Additional file 3. Extended patient characteristics at baseline.

Additional file 5. Results from follow-up measurements for the unmatched cohort.

Abstract Background Etanercept (ETN) and adalimumab (ADA) are considered equally effective biologicals in the treatment of arthritis in juvenile idiopathic arthritis (JIA) but no studies have compared their impact on patient-reported well-being. The objective of this study was to determine whether ETN and ADA have a differential effect on patient-reported well-being in non-systemic JIA using real-world data. Methods Biological-naive patients without a history of uveitis were selected from the international Pharmachild registry. Patients starting ETN...

Supplementary Material 1

Additional file 2. Interview guide. Description of data: Topical questions used in the interviews for data collection.